Physician profile
Anna C Arcaro
NPI 1992141626
$340.58
in general payments reported to CMS, 2019-2025
7 companies · $213 in 2025
The $213 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.49 · 2020: $22.57 · 2021: $13.72 · 2024: $24.48 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $179 · Food and Beverage: $34.52 · Long Term Medical Supply Or Device Loan: $24.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $178.80 |
| Food and Beverage | $34.52 |
| Long Term Medical Supply Or Device Loan | $24.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $203.28 | 2024-2025 | Hillrom - Connex Vital Signs Monitor, Hillrom - Spot Vision Screener |
| Merck Sharp & Dohme LLC | $39.78 | 2019-2021 | |
| Kaleo, INC. | $37.39 | 2019-2020 | |
| Glaxosmithkline, LLC. | $19.81 | 2025 | Nucala |
| Bavarian Nordic A/S | $14.71 | 2025 | Vivotif |
| Hologic Sales and Service, LLC | $14.54 | 2019 | |
| Phadia US INC. | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Arcaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.